Ayurvedic medicine to treat dengue to be launched within next 2 yrs: Ayush Ministry

Image
Press Trust of India New Delhi
Last Updated : Sep 24 2019 | 4:10 PM IST

An ayurvedic medicine to treat dengue is undergoing the third and final phase of clinical trials and will be launched within the next two years, a senior official of the Ayush Ministry said on Tuesday.

Ayush Secretary Vaidya Rajesh Kotecha said the research on this was being carried out by Ayush (Ayurveda, Yoga & Naturopathy, Unani, Siddha, Sowa Rigpa and Homoeopathy) Ministry and the Indian Council of Medical Research (ICMR).

It is made of a variety of ayurvedic herbs grown in India and is likely to hit the market within the next two years in the form of a pill.

"The research is in the third phase (final phase) of clinical trial. It will be done in the next two years. Once finished, this will be the world's first medicine against dengue," he said on the sidelines of a press conference on the achievements of the ministry in the last 100 days.

Details, such as the name of the medicine, how it will be sold - over the counter or through prescription - are yet to be decided. The ICMR and the ministry team will also have to work to standardise the dosage and fix the proportion of each herb used.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Sep 24 2019 | 4:10 PM IST

Next Story